Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Fodstad

Showing results (21-30 of 166) with videos related to

Pageof 17
Sort By:
Journal of the National Cancer Institute|February 1, 1995
Pronounced therapeutic effect of samarium 153-ethylenediaminetetramethylene phosphonate in an orthotopic human osteosarcoma tibial tumor modelM Winderen, I Kjønniksen, O Fodstad
Cancer Treatment Reviews|December 1, 1987
Some procedures to reduce cis-platinum toxicity reduce antitumour activityS Aamdal, O Fodstad, A Pihl
Annales Chirurgiae Et Gynaecologiae. Supplementum|January 1, 1985
The six-day subrenal capsule assay (SRCA) for testing the response of human tumours to anticancer agents. Validity and usefulness in cancer research and treatmentS Aamdal, O Fodstad, A Pihl
Cancer Chemotherapy and Pharmacology|January 1, 1988
Sodium thiosulfate fails to increase the therapeutic index of intravenously administered cis-diamminedichloroplatinum (II) in mice bearing murine and human tumorsS Aamdal, O Fodstad, A Pihl
Cancer Research|December 1, 1977
Inhibitory effect of abrin and ricin on the growth of transplantable murine tumors and of abrin on human cancers in nude miceO Fodstad, S Olsnes, A Pihl
Anticancer Research|July 1, 1985
Methodological aspects of the 6-day subrenal capsule assay for measuring the response of human tumors to anticancer agentsS Aamdal, O Fodstad, A Pihl
International Journal of Cancer|September 15, 1988
Kinetics of uptake and degradation of an abrin immunotoxin by melanoma cells and studies of the rates of cellular intoxicationA Godal, O Fodstad, A Pihl
British Journal of Cancer|April 1, 1987
Mitozolomide (NSC 353451), a new active drug in the treatment of malignant melanoma. Phase II trial in patients with advanced diseaseS Gundersen, S Aamdal, O Fodstad
International Journal of Cancer|June 15, 1985
The use of multicellular spheroids in establishing human sarcoma cell lines in vitroO Bruland, O Fodstad, A Pihl
Cancer Research|March 1, 1992
Site-dependent differences in sensitivity of LOX human melanoma tumors in nude rats to dacarbazine and mitozolomide, but not to doxorubicin and cisplatinI Kjønniksen, K Breistøl, O Fodstad
Pageof 17

Showing results (21-30 of 166) with videos related to

Sort By:
Pageof 17
Journal of the National Cancer Institute|February 1, 1995
Pronounced therapeutic effect of samarium 153-ethylenediaminetetramethylene phosphonate in an orthotopic human osteosarcoma tibial tumor modelM Winderen, I Kjønniksen, O Fodstad
Cancer Treatment Reviews|December 1, 1987
Some procedures to reduce cis-platinum toxicity reduce antitumour activityS Aamdal, O Fodstad, A Pihl
Annales Chirurgiae Et Gynaecologiae. Supplementum|January 1, 1985
The six-day subrenal capsule assay (SRCA) for testing the response of human tumours to anticancer agents. Validity and usefulness in cancer research and treatmentS Aamdal, O Fodstad, A Pihl
Cancer Chemotherapy and Pharmacology|January 1, 1988
Sodium thiosulfate fails to increase the therapeutic index of intravenously administered cis-diamminedichloroplatinum (II) in mice bearing murine and human tumorsS Aamdal, O Fodstad, A Pihl
Cancer Research|December 1, 1977
Inhibitory effect of abrin and ricin on the growth of transplantable murine tumors and of abrin on human cancers in nude miceO Fodstad, S Olsnes, A Pihl
Anticancer Research|July 1, 1985
Methodological aspects of the 6-day subrenal capsule assay for measuring the response of human tumors to anticancer agentsS Aamdal, O Fodstad, A Pihl
International Journal of Cancer|September 15, 1988
Kinetics of uptake and degradation of an abrin immunotoxin by melanoma cells and studies of the rates of cellular intoxicationA Godal, O Fodstad, A Pihl
British Journal of Cancer|April 1, 1987
Mitozolomide (NSC 353451), a new active drug in the treatment of malignant melanoma. Phase II trial in patients with advanced diseaseS Gundersen, S Aamdal, O Fodstad
International Journal of Cancer|June 15, 1985
The use of multicellular spheroids in establishing human sarcoma cell lines in vitroO Bruland, O Fodstad, A Pihl
Cancer Research|March 1, 1992
Site-dependent differences in sensitivity of LOX human melanoma tumors in nude rats to dacarbazine and mitozolomide, but not to doxorubicin and cisplatinI Kjønniksen, K Breistøl, O Fodstad
Pageof 17